5-141209016-G-A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_018932.4(PCDHB12):c.109G>A(p.Glu37Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,456,292 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018932.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCDHB12 | NM_018932.4 | c.109G>A | p.Glu37Lys | missense_variant | 1/1 | ENST00000239450.4 | NP_061755.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCDHB12 | ENST00000239450.4 | c.109G>A | p.Glu37Lys | missense_variant | 1/1 | NM_018932.4 | ENSP00000239450 | P1 | ||
ENST00000624192.1 | n.72+32657C>T | intron_variant, non_coding_transcript_variant | 5 | |||||||
PCDHB12 | ENST00000622978.1 | c.109G>A | p.Glu37Lys | missense_variant | 1/2 | 2 | ENSP00000485352 | |||
PCDHB12 | ENST00000624949.1 | c.-99+74G>A | intron_variant | 2 | ENSP00000485303 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1456292Hom.: 0 Cov.: 30 AF XY: 0.0000166 AC XY: 12AN XY: 724226
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 06, 2022 | The c.109G>A (p.E37K) alteration is located in exon 1 (coding exon 1) of the PCDHB12 gene. This alteration results from a G to A substitution at nucleotide position 109, causing the glutamic acid (E) at amino acid position 37 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.